Cogent Biosciences
$38.5
44
+$3.11+8.79% Tuesday 20:00
Statistics
Day High
39.41
Day Low
35.93
52W High
43.73
52W Low
3.72
Volume
4,494,621
Avg. Volume
2,053,001
Mkt Cap
6.25B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.532603
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-657.87MNet Income
Analyst Ratings
$47.63Average Price Target
The highest estimate is 67.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow COGT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Novartis
NVS
Mkt Cap237.61B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Beam Therapeutics
BEAM
Mkt Cap2.53B
PTC Therapeutics
PTCT
Mkt Cap5.4B
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
About
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Andrew R. Robbins M.B.A.
Employees
205
Country
US
ISIN
US19240Q2012
Listings
0 Comments
Share your thoughts
FAQ
What is Cogent Biosciences stock price today?▼
The current price of COGT is $38.5 USD — it has increased by +8.79% in the past 24 hours. Watch Cogent Biosciences stock price performance more closely on the chart.
What is Cogent Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cogent Biosciences stocks are traded under the ticker COGT.
Is Cogent Biosciences stock price growing?▼
COGT stock has risen by +5.48% compared to the previous week, the month change is a -0.9% fall, over the last year Cogent Biosciences has showed a +564.94% increase.
What is Cogent Biosciences market cap?▼
Today Cogent Biosciences has the market capitalization of 6.25B
When is the next Cogent Biosciences earnings date?▼
Cogent Biosciences is going to release the next earnings report on May 12, 2026.
What were Cogent Biosciences earnings last quarter?▼
COGT earnings for the last quarter are -0.61 USD per share, whereas the estimation was -0.58 USD resulting in a -6.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cogent Biosciences revenue for the last year?▼
Cogent Biosciences revenue for the last year amounts to 0 USD.
What is Cogent Biosciences net income for the last year?▼
COGT net income for the last year is -657.87M USD.
How many employees does Cogent Biosciences have?▼
As of April 01, 2026, the company has 205 employees.
In which sector is Cogent Biosciences located?▼
Cogent Biosciences operates in the Health Care sector.
When did Cogent Biosciences complete a stock split?▼
The last stock split for Cogent Biosciences was on November 09, 2020 with a ratio of 1:4.
Where is Cogent Biosciences headquartered?▼
Cogent Biosciences is headquartered in Waltham, US.